|
Market Closed -
Nasdaq Stockholm
09:30:00 11/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1.848 SEK | -2.63% |
|
+8.07% | -6.19% |
| 03/09 | Irlab CEO Kristina Torfgaard to step down in 2027 | FW |
| 03/09 | Irlab CEO Kristina Torfgaard wants to step down | FW |
| Market Cap | 27Cr 2.84Cr 2.44Cr 2.31Cr 2.1Cr 3.93Cr 270.97Cr 3.95Cr 11Cr 137.86Cr 11Cr 10Cr 435.61Cr | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 27Cr 2.84Cr 2.44Cr 2.31Cr 2.1Cr 3.93Cr 270.97Cr 3.95Cr 11Cr 137.86Cr 11Cr 10Cr 435.61Cr | EV / Sales 2026 * |
2.72x | EV / Sales 2027 * | 1.92x |
| Free-Float |
83.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| IRLAB A | Delayed | |
Deutsche Boerse AG
| 6IRA | Delayed |
Last Transcript : IRLAB Therapeutics AB
| 1 day | -2.63% | ||
| 1 week | +8.07% | ||
| Current month | +3.12% | ||
| 1 month | +14.07% | ||
| 3 months | +48.79% | ||
| 6 months | +15.93% | ||
| Current year | -6.19% |
| 1 week | 1.72 |  | 1.96 |
| 1 month | 1.59 | | 1.96 |
| Current year | 1.17 | | 2.14 |
| 1 year | 1.17 | | 3.08 |
| 3 years | 1.17 | | 20.2 |
| 5 years | 1.17 | | 51.6 |
| 10 years | 1.17 | | 110 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 01/08/2024 | |
Susanna Waters
PRN | Corporate Officer/Principal | 60 | 01/01/2013 |
Clas Sonesson
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Rein Piir
BRD | Director/Board Member | 68 | 01/01/2016 |
| Chairman | 73 | 07/05/2020 | |
| Chairman | 68 | 20/02/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/07/26 | Buy | Chairman | 31,000 | 38.8588% | ||
| 01/07/26 | Buy | Chief Technology Officer | 40,16,742 | - | ||
| 01/07/26 | Buy | Chief Executive Officer | 1,83,858 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.63% | +8.07% | -36.82% | -75.75% | 2.84Cr | |
| -0.65% | -2.93% | +47.70% | +86.30% | 99TCr | |
| -0.29% | -3.51% | +49.15% | +61.95% | 64TCr | |
| +0.83% | +0.26% | +17.76% | +70.10% | 45TCr | |
| -0.38% | -3.59% | +30.13% | +34.14% | 34TCr | |
| -0.09% | -13.54% | +13.34% | +24.74% | 26TCr | |
| -0.43% | -2.48% | -0.73% | +10.64% | 25TCr | |
| -1.34% | -13.70% | +36.53% | +46.70% | 20TCr | |
| -3.44% | -7.51% | -20.63% | -58.97% | 19TCr | |
| -0.75% | -4.82% | +25.46% | +85.90% | 18TCr | |
| Average | -0.92% | -4.38% | +16.19% | +28.57% | 35.05TCr | |
| Weighted average by Cap. | -0.51% | -4.42% | +30.96% | +54.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10Cr 1.04Cr 89.99L 85.21L 77.23L 1.45Cr 100Cr 1.46Cr 3.89Cr 51Cr 3.92Cr 3.84Cr 160.41Cr | 14Cr 1.48Cr 1.27Cr 1.21Cr 1.09Cr 2.05Cr 141.19Cr 2.06Cr 5.51Cr 72Cr 5.55Cr 5.43Cr 226.98Cr |
| Net income | -3.61Cr -37.26L -32.1L -30.4L -27.55L -51.69L -36Cr -51.95L -1.39Cr -18Cr -1.4Cr -1.37Cr -57Cr | 3.46Cr 35.71L 30.77L 29.13L 26.41L 49.54L 34Cr 49.79L 1.33Cr 17Cr 1.34Cr 1.31Cr 55Cr |
| Net Debt | - | - |
Employees
31
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | SEK 1.848 | -2.63% | 8,92,995 |
| 10/26/10 | SEK 1.898 | +0.96% | 9,28,473 |
| 09/26/09 | SEK 1.880 | +5.50% | 13,96,457 |
| 08/26/08 | SEK 1.782 | +3.24% | 7,01,646 |
| 07/26/07 | SEK 1.726 | +0.94% | 4,09,799 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IRLAB A Stock
Select your edition
All financial news and data tailored to specific country editions
